- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00928616
Differential Effects of a Diet Supplementation With Plant Sterol Esters on Human Monocytes (PSE-MO)
June 25, 2009 updated by: University Hospital, Saarland
Differential Effects of "Functional Foods" Supplemented With Plant Sterol Esters on Blood Cells and Serum Parameters.
The purpose of this study is to evaluate the effects of a diet supplementation with plant sterol esters on serum lipids, plant sterol concentrations and monocyte subpopulations.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
This study investigates effects of a diet supplementation with plant sterol esters on serum lipids, plant sterol concentrations and monocyte subpopulations.
Study Type
Interventional
Enrollment (Actual)
16
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Saarland
-
Homburg, Saarland, Germany, 66421
- Universitätsklinikum des Saarlandes, Klinik für Innere Medizin III
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 61 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- healthy individuals without known cardiovascular diseases
Exclusion Criteria:
- drugs that interfere with cholesterol metabolism
- other use of dietary supplements
- vegetarianism
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: plant sterol esters
Participants consume plant sterol ester supplemented margarine (3 g/day)
|
margarine supplemented with plant sterol esters (3g/day) over the time period of 4 weeks
Other Names:
|
|
Placebo Comparator: Placebo
Placebo is a non-sterol ester supplemented margarine
|
non-sterol ester supplemented margarine
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
monocyte subpopulations
Time Frame: 4 weeks
|
4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
serum parameters (lipids, plant sterol concentrations, inflammation parameters)
Time Frame: 4 weeks
|
4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Oliver Weingärtner, MD, Universitätsklinikum des Saarlandes, Klinik für Innere Medizin III
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2009
Primary Completion (Anticipated)
June 1, 2009
Study Completion (Anticipated)
June 1, 2009
Study Registration Dates
First Submitted
June 25, 2009
First Submitted That Met QC Criteria
June 25, 2009
First Posted (Estimate)
June 26, 2009
Study Record Updates
Last Update Posted (Estimate)
June 26, 2009
Last Update Submitted That Met QC Criteria
June 25, 2009
Last Verified
June 1, 2009
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 108/07
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hyperlipidemia
-
CSPC Ouyi Pharmaceutical Co., Ltd.Not yet recruitingPrimary Hyperlipidemia
-
Gan & Lee Pharmaceuticals.RecruitingPrimary HyperlipidemiaChina
-
Drug Commission of the German Medical AssociationMadaus AGTerminatedHypercholesterolemia | Combined Hyperlipidemia
-
Misr University for Science and TechnologyActive, not recruiting
-
DongKoo Bio & PharmaUnknownHyperlipidemia, HypertriglyceridemiaKorea, Republic of
-
Chengdu Diao Jiuhong Pharmaceutical FactoryRecruiting
-
Washington University School of MedicineRecruitingHypercholesterolemia and HyperlipidemiaUnited States
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingHypercholesterolemia and HyperlipidemiaChina
-
Jiangsu HengRui Medicine Co., Ltd.CompletedHypercholesterolemia and HyperlipidemiaChina
-
Dr. Md. Alimur RezaRecruitingHyperlipidemia (E.G., Hypercholesterolemia)Bangladesh
Clinical Trials on margarine + plant sterol esters
-
Maastricht University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompleted
-
Maastricht University Medical CenterUnilever R&D; Raisio Group; BASFUnknownNon-Alcoholic Fatty Liver DiseaseNetherlands
-
French Cardiology SocietyFondation Coeur et ArtèresWithdrawnHypercholesterolemiaFrance
-
Inner Mongolia Yili Industrial Group Co., LtdCompletedHypercholesterolemiaChina
-
Maastricht University Medical CenterNot yet recruiting
-
Maastricht University Medical CenterRaisio GroupCompleted
-
University of HelsinkiUniversity of Eastern FinlandCompleted
-
Unilever R&DCompletedVascular Diseases | HypercholesterolemiaGermany
-
Piper Biosciences, Inc.UnknownHyperlipidemiaUnited States
-
Stanford UniversityPiper Biosciences, Inc.CompletedCardiovascular Risk FactorUnited States